Integrity Applications

Founded with the mission to revolutionize diabetes care, Integrity Applications, through its brand GlucoTrack, designs, develops, and commercializes non-invasive glucose monitoring devices. Their core vision is to provide a less intrusive and more comfortable means for people with diabetes to monitor their blood glucose levels. The company's primary product, the GlucoTrack device, offers continuous glucose monitoring (CGM) that helps users track their glucose levels, manage medication dosages, and gain insights into glucose trends. Their market focus spans the United States and Israel.

Key figures affiliated with Integrity Applications include notable investors and medical device experts who have supported the company's innovative approach. The company has achieved significant milestones in non-invasive glucose monitoring technology, earning recognition within the medical industry. By offering an alternative to traditional invasive methods, Integrity Applications has made a substantial impact on improving the quality of life for individuals with diabetes, enhancing their ability to manage their condition effectively.